Transpulmonary Pressure-Guided Ventilation Weaning for Obesity-Related Respiratory Issues
Trial Summary
What is the purpose of this trial?
This study will look at whether accounting for the amount of pressure generated by the chest wall and abdomen in a obese patient, using a measurement called transpulmonary pressure, can help shorten the amount of time patients spend on the ventilator. By decreasing the amount of time patients spend on the ventilator, they are less likely to develop complications such as infections, weakness or more procedures.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of transpulmonary pressure-guided ventilation weaning for obesity-related respiratory issues?
Is transpulmonary pressure-guided ventilation safe for humans?
Transpulmonary pressure-guided ventilation, which uses esophageal pressure monitoring, is considered minimally invasive and has been used to guide ventilation support in various conditions, including acute respiratory distress syndrome. It helps in adjusting ventilation settings to potentially reduce the risk of lung injury during mechanical ventilation.12356
How is transpulmonary pressure-guided PEEP different from other treatments for obesity-related respiratory issues?
Transpulmonary pressure-guided PEEP is unique because it uses esophageal pressure measurements to tailor the ventilation settings specifically for obese patients, potentially improving lung function and oxygen levels more effectively than traditional methods. This approach is particularly beneficial for patients with high pleural pressures, which are common in obesity, and aims to optimize mechanical ventilation by individualizing treatment.12378
Eligibility Criteria
This trial is for obese patients (BMI ≥ 35.0 kg/m²) who have been on a ventilator for less than 48 hours due to respiratory failure. It's not suitable for those with esophageal or gastrointestinal issues, low platelet counts, neuromuscular diseases, difficult airways, life expectancy under 48 hours, prior chronic ventilation needs, severe neurological injuries or known pleural diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Transpulmonary pressure guided positive end expiratory pressure (PEEP) titration for ventilation and spontaneous breathing trials (SBT) to shorten the time to liberation from mechanical ventilation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including mortality, ICU and hospital length of stay, and re-intubation rates
Treatment Details
Interventions
- standard positive end expiratory pressure
- transpulmonary pressure guided positive end expiratory pressure
transpulmonary pressure guided positive end expiratory pressure is already approved in United States, European Union for the following indications:
- Mechanical ventilation management in obese patients
- ARDS management
- Mechanical ventilation optimization in obese patients
- ARDS treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Mississippi Medical Center
Lead Sponsor